The Israel Innovation Authority has selected Nebius, via competitive bidding, to build Israel's national supercomputer.1 The project's fate now hinges partly on decisions made in Washington, not Jerusalem.
Large-scale supercomputing projects of this kind typically depend on advanced AI chips, such as Nvidia's, that fall under US export control rules.1 Any delay or denial of export licenses for those chips could stall the buildout or force Israel to restructure the project entirely.
Analysts assess this regulatory risk as major in severity, with medium likelihood.1 The assessment carries a confidence level of 0.7, reflecting real but not certain exposure.
US export controls on advanced AI chips have tightened in recent years, targeting China but also creating friction for allied nations pursuing sovereign compute capacity. Even approved partners can face review delays, licensing conditions, or shifting rules as Washington recalibrates its chip policy.
For Israel, the stakes go beyond one contract. A national supercomputer underpins AI research, defense applications, and innovation funding priorities the Innovation Authority is tasked with advancing.1 A stalled build would ripple into those broader ambitions.
Nebius, as the selected builder, now carries execution risk tied directly to US regulatory timelines it does not control. Any restructuring driven by export denials could mean sourcing alternative chips, redesigning the system architecture, or delaying deployment timelines.
The episode underscores a broader pattern: national supercomputing ambitions worldwide increasingly run through US export policy on advanced AI chips. Governments backing sovereign compute projects face a dependency they cannot engineer around, only negotiate.
No timeline for chip procurement or export license applications has been disclosed. The Innovation Authority has not indicated a contingency plan should licensing be delayed or denied.